2026 Biomarkers of Aging Conference
Dr. Chiara Herzog vice-chairs the 2026 Biomarkers of Aging Conference at Harvard Medical School.
exposures, including smoking, viral infections, early-life adversity, pollution, and others.
current cellular state and gene expression
health trajectories and cell fate
Measure: quantifiable markers of disease risk and ageing.
Modify: leverage epigenome to modulate health trajectories and cell fates.
Unlocking the epigenetic code
Our research investigates how the epigenome encodes biological experiences, how this encoding shapes stem cell function across tissues, and whether these mechanisms can be measured non-invasively and causally modulated to influence ageing and disease trajectories.
Defining how DNA methylation encodes biological experience across tissues and stem cells.
Translating epigenetic memory into non-invasive biomarkers that capture vulnerability, resilience, and disease risk before clinical onset.
Using experimental systems to test whether epigenetic states causally influence stem cell behaviour and ageing.
Pushing the boundaries of geroscience
Leading research in epigenetics to transform how we understand and modulate ageing.
Jordan is an undergraduate student working on large-scale data harmonisation and improvement of computational tools for ageing research.
Peter Brederlow is a visiting MSc student from the University of Tübingen, studying Bioinformatics
Stay connected with our research through talks, workshops, and other events.
Dr. Chiara Herzog vice-chairs the 2026 Biomarkers of Aging Conference at Harvard Medical School.
Dr. Chiara Herzog joins the 2026 GRC Systems Aging Conference in Newry, Maine.
Dr. Chiara Herzog joins Foresight Institute's first UK Vision Weekend as a community partner.
Department of Twin Research & Genetic Epidemiology
St. Thomas' Hospital
Westminster Bridge Road
SE1 7EH
London
United Kingdom